GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

Physical activity programmes such as the NSC can help mitigate rising obesity and T2DM prevalence when implemented at the population level, as seen in Singapore. However, their success depends on ...

Neuropathological confirmation of Alzheimer's disease is defined by the presence of extracellular amyloid-β plaques and intracellular neurofibrillary tau tangles. A central challenge to the ...

The DIRECT ANGIO randomised clinical trial by Benjamin Gory and colleagues1 in The Lancet Neurology was designed to test a biologically compelling premise: that a direct transfer to angiography suite ...

As the inaugural Director of the new Parkinson's Research Centre, funded by the UK Dementia Research Institute and Parkinson's UK, Professor Miratul Muqit (University of Dundee, UK) hopes to untangle ...

In 2023, the burden of stroke accounted for approximately 157 million disability-adjusted life years (DALYs), ranking second among all non-communicable diseases globally. Although age-standardised ...